Everest Organics Limited (EVERESTO.BO)

INR 257.5

(4.99%)

Total Liabilities Summary of Everest Organics Limited

Everest Organics Limited's latest annual total liabilities in 2023 was 1.8 Billion INR , up 16.22% from previous year.
Everest Organics Limited's latest quarterly total liabilities in 2024 Q1 was 1.89 Billion INR , up 4.59% from previous quarter.
Everest Organics Limited reported annual total liabilities of 1.55 Billion INR in 2022, up 18.62% from previous year.
Everest Organics Limited reported annual total liabilities of 1.31 Billion INR in 2021, up 47.75% from previous year.
Everest Organics Limited reported quarterly total liabilities of 1.8 Billion INR for 2023 Q4, up 1.04% from previous quarter.
Everest Organics Limited reported quarterly total liabilities of 1.6 Billion INR for 2023 Q1, up 3.23% from previous quarter.

Annual Total Liabilities Chart of Everest Organics Limited (2023 - 2012)

Historical Annual Total Liabilities of Everest Organics Limited (2023 - 2012)

Year	Total Liabilities	Total Liabilities Growth
2023	1.8 Billion INR	16.22%
2022	1.55 Billion INR	18.62%
2021	1.31 Billion INR	47.75%
2020	888.02 Million INR	3.15%
2019	860.89 Million INR	5.89%
2018	813.02 Million INR	7.54%
2017	756.05 Million INR	8.07%
2016	699.56 Million INR	0.11%
2015	698.8 Million INR	14.82%
2014	608.62 Million INR	-0.71%
2013	613 Million INR	17.13%
2012	523.35 Million INR	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q1	1.89 Billion INR	4.59%
2023 Q4	1.8 Billion INR	1.04%
2023 Q1	1.6 Billion INR	3.23%
2023 FY	1.8 Billion INR	16.22%
2023 Q3	1.79 Billion INR	2.81%
2023 Q2	1.74 Billion INR	8.39%
2022 Q3	1.51 Billion INR	2.39%
2022 FY	1.55 Billion INR	18.62%
2022 Q2	1.48 Billion INR	3.99%
2022 Q1	1.42 Billion INR	8.49%
2022 Q4	1.55 Billion INR	2.68%
2021 Q2	1.07 Billion INR	8.06%
2021 Q1	990.66 Million INR	11.56%
2021 Q3	1.22 Billion INR	14.47%
2021 FY	1.31 Billion INR	47.75%
2021 Q4	1.31 Billion INR	7.07%
2020 Q1	885.43 Million INR	2.85%
2020 Q3	887.91 Million INR	8.46%
2020 Q4	888.02 Million INR	0.01%
2020 FY	888.02 Million INR	3.15%
2020 Q2	818.63 Million INR	-7.54%
2019 FY	860.89 Million INR	5.89%
2019 Q3	- INR	-100.0%
2019 Q4	860.89 Million INR	0.0%
2019 Q2	839.3 Million INR	-2.99%
2019 Q1	865.14 Million INR	6.41%
2018 Q4	813.02 Million INR	3.71%
2018 FY	813.02 Million INR	7.54%
2018 Q3	783.93 Million INR	5.22%
2018 Q2	745.02 Million INR	0.0%
2018 Q1	- INR	-100.0%
2017 Q3	- INR	-100.0%
2017 Q1	- INR	-100.0%
2017 Q2	731.64 Million INR	0.0%
2017 Q4	756.05 Million INR	0.0%
2017 FY	756.05 Million INR	8.07%
2016 Q2	675.32 Million INR	0.0%
2016 Q1	- INR	-100.0%
2016 Q4	699.56 Million INR	0.0%
2016 FY	699.56 Million INR	0.11%
2015 Q4	698.8 Million INR	0.0%
2015 FY	698.8 Million INR	14.82%
2014 FY	608.62 Million INR	-0.71%
2014 Q4	608.62 Million INR	0.0%
2013 Q2	531.79 Million INR	-3.45%
2013 Q4	613 Million INR	4.85%
2013 Q1	550.78 Million INR	5.24%
2013 Q3	584.64 Million INR	9.94%
2013 FY	613 Million INR	17.13%
2012 FY	523.35 Million INR	0.0%
2012 Q4	523.35 Million INR	0.0%

Peer Total Liabilities Comparison of Everest Organics Limited

Name	Total Liabilities	Total Liabilities Difference
Chandra Bhagat Pharma Limited	727.95 Million INR	-148.481%
Checkpoint Trends Limited	4 Million INR	-45038.81%
GUJARAT INJECT (KERALA) LTD.	1.47 Million INR	-122866.281%
NATURO INDIABULL LIMITED	537.34 Million INR	-236.624%
NEXUS SURGICAL AND MEDICARE LI	12.39 Million INR	-14487.43%
Rajnish Wellness Limited	222.75 Million INR	-712.021%
Rama Vision Limited	291.78 Million INR	-519.912%
Vivo Bio Tech Limited	827.33 Million INR	-118.633%